Related Experiment Video
Updated: Aug 6, 2026
14:55
Methods to Quantify Pharmacologically Induced Alterations in Motor Function in Human Incomplete SCI
Published on: April 18, 2011
PRP and SCI therapy: Mechanisms, translation and challenges
Jian-Gen Ye1, Xin Zhang2, Wen-Jun Zhang1
1Department of Rehabilitation Medicine, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang City, Jiangxi Province, China.
Tissue & Cell
|July 24, 2026
Summary
Platelet-rich plasma (PRP) shows potential for spinal cord injury (SCI) recovery by aiding nerve regeneration and reducing inflammation. However, more clinical evidence is needed to confirm its effectiveness in treating SCI patients.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Biomaterials
Background:
- Spinal cord injury (SCI) leads to significant sensory and motor deficits, including paralysis and chronic pain, severely impacting patient quality of life.
- Current treatments for SCI lack selectivity and efficacy in promoting functional recovery.
- Platelet-rich plasma (PRP), derived from autologous blood, contains growth factors that promote tissue regeneration and has emerged as a potential therapeutic agent.
Purpose of the Study:
- To review the functional role of PRP in treating spinal cord injuries.
- To evaluate the therapeutic potential and clinical value of PRP for SCI.
- To identify current challenges in the clinical application of PRP for SCI.
Main Methods:
- Review of existing literature on PRP and its application in SCI models and clinical studies.
- Analysis of PRP's mechanisms of action, including nerve regeneration, anti-inflammation, and angiogenesis.
- Discussion of clinical trial data and controversies surrounding PRP efficacy in SCI.
Main Results:
- PRP and its exosomes demonstrate potential in promoting axon regeneration, myelination, and angiogenesis in SCI.
- PRP exhibits anti-inflammatory effects and aids in protecting the blood-spinal cord barrier (BSCB).
- PRP may help regulate neuropathic pain associated with SCI.
Conclusions:
- PRP offers a promising therapeutic strategy for SCI by targeting multiple pathological aspects of the injury.
- While preclinical data is encouraging, high-quality clinical evidence is limited, leading to ongoing debate about PRP's efficacy in human SCI treatment.
- Further rigorous clinical trials are necessary to establish the definitive role and optimize the application of PRP in SCI management.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:24Ribosome Profiling
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
02:33Initiation of Translation
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...